Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-25

Clinical Trial Update: PArtial REbreathing for Migraine With Aura 1 [NA]

View source ↗

Summary

The clinical trial evaluating partial rebreathing for migraine with aura (NCT05546385) has been terminated; results were posted on 2025-03-25.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Rehaler | Conditions: Migraine With Aura | NA | Status: TERMINATED | Results posted: 2025-03-25